Masseter Muscle Hypertrophy

Kern, Arthur B.

doi:10.1001/archderm.1954.01540170028004

Cited by 18 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was in 1880 when Legg witnessed concurrent idiopathic temporalis muscle hypertrophy in a 10‐year‐old girl and subsequently described it as masseter muscle hypertrophy. Hypertrophy of masseters can change the facial lines, making the patients more conscious and skeptical about their appearance 3 . Numerous modalities are available to reduce the bulk of the lower of half of the face, including the surgical and nonsurgical modalities.…”

Section: Introductionmentioning

confidence: 99%

Efficacy of Incobotulinum toxin‐A for the treatment of masseter muscle hypertrophy in Asian Indian patients: A 2‐year follow‐up study

Shome

Vadera²,

Ram

et al. 2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background With the changing trends, more and more patients are opting for nonsurgical or minimally invasive options for reshaping the face. Noninvasive treatments such as incobotulinumtoxinA (Xeomin Cosmetic®; Merz Pharma Canada Ltd., Burlington, ON, Canada) are a preferred modality for reducing the volume of the muscle and therefore reducing the width of masseter. Aims To evaluate the efficacy of Xeomin treatment in long‐term management of bilateral masseter hypertrophy in Asian Indian patients. Patients/Methods A total of 30 patients were enrolled in the study and were injected with 30 U Xeomin on each side of face, at baseline. Fifteen patients received a second session of Xeomin injection at 12th week, and remaining 15 patients received an additional third session, at 12th and 24th weeks post the first injection, respectively. Follow‐up was done at 4th‐, 12th‐, 24th‐, and 36th‐week and at first‐ and second‐year follow‐ups. Results For the patients who received two injections, the maximum reduction of 26.85% was observed at 24th week, which was maintained as 20.04% reduction until second follow‐up year. The patients who received three injections exhibited very high reduction of 43.12% of masseter volume at 36th week, which was maintained at 38.72 % until the second follow‐up year. Three sessions of Xeomin injections were proved to be more effective in long‐term maintenance of reduced masseter volume than 2 sessions of injections. Conclusions Xeomin injections were found to be effective in long‐term management of bilateral masseter hypertrophy. This is the first of its kind paper, which evaluates the long‐term effects of Xeomin injections for the treatment of masseter hypertrophy.

show abstract

Section: Introductionmentioning

confidence: 99%

Efficacy of Incobotulinum toxin‐A for the treatment of masseter muscle hypertrophy in Asian Indian patients: A 2‐year follow‐up study

Shome

Vadera²,

Ram

et al. 2020

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

“…This condition is uncommon and was first described in a child at St Bartholomew's Hospital in 1880 by Legg. There have been a number of reports since, mostly in the American literature and during the period [1942][1943][1944][1945][1946][1947][1948][1949][1950][1951][1952][1953][1954][1955] (Coffey 1942, Hersh 1946, Gurney 1947, Maxwell & Waggoner 1951, Tempest 1951, Soderberg & Switzer 1954, Kern 1954, Drummond & McIntosh 1954, Masters et al 1955). The condition is commonest in the age group 20-40 years; no case has yet been reported in an old person, and it is possible that the swellings recede spontaneously over the years.…”

Section: Commentmentioning

confidence: 99%

Hypertrophy of the Masseter Muscles

Jc¹

1962

Proceedings of the Royal Society of Medicine

View full text Add to dashboard Cite

“…This condition is uncommon and was first described in a child at St Bartholomew's Hospital in 1880 by Legg. There have been a number of (Coffey 1942, Hersh 1946, Gurney 1947, Maxwell & Waggoner 1951, Tempest 1951, Soderberg & Switzer 1954, Kern 1954, Drummond & McIntosh 1954, Masters et al 1955. The condition is commonest in the age group 20-40 years; no case has yet been reported in an old person, and it is possible that the swellings recede spontaneously over the years.…”

Section: Commentmentioning

confidence: 99%